Annual CFI
-$20.00 K
+$119.00 K+85.61%
31 December 2023
Summary:
BioXcel Therapeutics annual cash flow from investing activities is currently -$20.00 thousand, with the most recent change of +$119.00 thousand (+85.61%) on 31 December 2023. During the last 3 years, it has risen by +$296.00 thousand (+93.67%).BTAI Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$0.00
$0.000.00%
30 September 2024
Summary:
BioXcel Therapeutics quarterly cash flow from investing activities is currently $0.00, unchanged on 30 September 2024. Over the past year, it has stayed the same.BTAI quarterly CFI is now -100.00% below its all-time high of $5000.00, reached on 30 September 2020.BTAI Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$0.00
$0.000.00%
30 September 2024
Summary:
BioXcel Therapeutics TTM cash flow from investing activities is currently $0.00, unchanged on 30 September 2024. Over the past year, it has increased by +$20.00 thousand (+100.00%).BTAI TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BTAI Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +85.6% | 0.0% | +100.0% |
| 3 y3 years | +93.7% | +100.0% | +100.0% |
| 5 y5 years | +94.1% | +100.0% | +100.0% |
BTAI Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +95.5% | +100.0% | +100.0% | ||
| 5 y | 5 years | at high | +97.7% | -100.0% | +100.0% | +100.0% | |
| alltime | all time | <-9999.0% | +97.7% | -100.0% | +100.0% | at high | +100.0% |
BioXcel Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2024 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2024 | - | $0.00(0.0%) | -$20.00 K(0.0%) |
| Dec 2023 | -$20.00 K(-85.6%) | $0.00(0.0%) | -$20.00 K(0.0%) |
| Sept 2023 | - | $0.00(-100.0%) | -$20.00 K(0.0%) |
| June 2023 | - | -$20.00 K(<-9900.0%) | -$20.00 K(+5.3%) |
| Mar 2023 | - | $0.00(0.0%) | -$19.00 K(-86.3%) |
| Dec 2022 | -$139.00 K(-68.8%) | $0.00(0.0%) | -$139.00 K(-7.9%) |
| Sept 2022 | - | $0.00(-100.0%) | -$151.00 K(-10.1%) |
| June 2022 | - | -$19.00 K(-84.2%) | -$168.00 K(-32.5%) |
| Mar 2022 | - | -$120.00 K(+900.0%) | -$249.00 K(-44.0%) |
| Dec 2021 | -$445.00 K(+40.8%) | -$12.00 K(-29.4%) | -$445.00 K(-36.7%) |
| Sept 2021 | - | -$17.00 K(-83.0%) | -$703.00 K(+3.2%) |
| June 2021 | - | -$100.00 K(-68.4%) | -$681.00 K(+10.6%) |
| Mar 2021 | - | -$316.00 K(+17.0%) | -$616.00 K(+94.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | -$316.00 K(-63.7%) | -$270.00 K(-5500.0%) | -$316.00 K(+558.3%) |
| Sept 2020 | - | $5000.00(-114.3%) | -$48.00 K(-50.0%) |
| June 2020 | - | -$35.00 K(+118.8%) | -$96.00 K(-66.4%) |
| Mar 2020 | - | -$16.00 K(+700.0%) | -$286.00 K(-67.1%) |
| Dec 2019 | -$870.00 K(+155.9%) | -$2000.00(-95.3%) | -$870.00 K(-15.2%) |
| Sept 2019 | - | -$43.00 K(-80.9%) | -$1.03 M(-1.8%) |
| June 2019 | - | -$225.00 K(-62.5%) | -$1.04 M(+11.2%) |
| Mar 2019 | - | -$600.00 K(+279.7%) | -$940.00 K(+176.5%) |
| Dec 2018 | -$340.00 K(<-9900.0%) | -$158.00 K(+154.8%) | -$340.00 K(+86.8%) |
| Sept 2018 | - | -$62.00 K(-48.3%) | -$182.00 K(+51.7%) |
| June 2018 | - | -$120.00 K(<-9900.0%) | -$120.00 K(<-9900.0%) |
| Mar 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2017 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2017 | - | $0.00 | $0.00 |
| Dec 2016 | -$4000.00 | - | - |
FAQ
- What is BioXcel Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for BioXcel Therapeutics?
- What is BioXcel Therapeutics annual CFI year-on-year change?
- What is BioXcel Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for BioXcel Therapeutics?
- What is BioXcel Therapeutics quarterly CFI year-on-year change?
- What is BioXcel Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for BioXcel Therapeutics?
- What is BioXcel Therapeutics TTM CFI year-on-year change?
What is BioXcel Therapeutics annual cash flow from investing activities?
The current annual CFI of BTAI is -$20.00 K
What is the all time high annual CFI for BioXcel Therapeutics?
BioXcel Therapeutics all-time high annual cash flow from investing activities is $0.00
What is BioXcel Therapeutics annual CFI year-on-year change?
Over the past year, BTAI annual cash flow from investing activities has changed by +$119.00 K (+85.61%)
What is BioXcel Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of BTAI is $0.00
What is the all time high quarterly CFI for BioXcel Therapeutics?
BioXcel Therapeutics all-time high quarterly cash flow from investing activities is $5000.00
What is BioXcel Therapeutics quarterly CFI year-on-year change?
Over the past year, BTAI quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is BioXcel Therapeutics TTM cash flow from investing activities?
The current TTM CFI of BTAI is $0.00
What is the all time high TTM CFI for BioXcel Therapeutics?
BioXcel Therapeutics all-time high TTM cash flow from investing activities is $0.00
What is BioXcel Therapeutics TTM CFI year-on-year change?
Over the past year, BTAI TTM cash flow from investing activities has changed by +$20.00 K (+100.00%)